The Two Sister Study, funded in part by Susan Komen for the Cure, was conducted to examine the possible risks associated with fertility drugs and breast cancer. The results were published July 6 in the Journal of The National Cancer Institute. (Source: Drug Topics - Top News) read more..
Metastatic Breast Cancer Cells Diminish Body’s Immune Response
A new study suggests suppression of breast cancer metastasis relies on an antitumor immune response. Researchers found that administering interferon can reduce bone metastases and increase the survival time of a metastatic breast cancer mouse model. (Source: Cancer Network) read more..
[News] Lapatinib or trastuzumab in combination with an aromatase inhibitor for first-line treatment of metastatic hormone-receptor-positive breast cancer that overexpresses HER2
On 27 June, 2012, NICE published guidance which did not recommend lapatinib or trastuzumab in combination with an aromatase inhibitor for first-line treatment in postmenopausal women with metastatic hormone-receptor-positive breast cancer that overexpresses HER2. (Source: The Lancet Oncology) read more..
No comments:
Post a Comment